4CPS-125 Use of eribulin in locally advanced or metastatic breast cancer

BACKGROUND: Eribulin has been approved for locally advanced or metastatic breast cancer after at least one previous chemotherapy regimen for advanced disease, including an anthracycline and a taxane. PURPOSE: To evaluate the effectiveness and safety of eribulin in a tertiary-level hospital. MATERIAL...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur J Hosp Pharm
Главные авторы: Rey, MB Contreras, Martínez, MT Garrido, Madroñal, IM Carrión, Feria, D Yáñez, Gómez, E Sánchez, Martin, C Bocanegra
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2018
Предметы:
Section 4: Clinical pharmacy services
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535592/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.216
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы